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Abstract Kirromycin inhibits bacterial protein synthesis by 
acting on elongation factor Tu (EF-Tu). Complexes of the 
antibiotic, Phe-tRNAPhe, the guanosine triphosphate analog 
GDPNP, and mesophilic (Eschericlria coli), as well as thermo- 
philic (Thermus thermophifus) EF-Tu were isolated. Crystal- 
lization was achieved at 4’C, pH 6.4, using ammonium sulphate 
as precipitant. Crystallographic data were recorded at cryogenic 
temperature on crystals exposed to synchrotron radiation. 
Crystals of the thermophillc complex are Pased on a rhombohe- 
dral lattice with cell dimensions of 137.3 A, and angles of 54.0“. 
Although related, these cell parameters are different from those 
found in the crystals of the recently solved structure of the 
ternary complex of Phe-tRNAPhe, GDPNP, and Thermus 
aquaticus EF-Tu (Nissen, P., Kjeldgaard, M., Thirup, S., 
Polekhina, G., Reshetnikova, L., Clark, B.F. and Nyborg, J. 
(1995) Science 270, 1464-1472 [l]), possibly indicating some 
allosteric effect caused by kirromycin. Crystals of the mesophilic 
$omplex belong to the cubic space P432, with cell axis of 196.26 
A. In both cases, the crystals contain one complex per 
asymmetric unit. 
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1. Introduction 
The ribosomal particle provides a large macromolecular 
structure, which serves as a scaffold for protein biosynthesis. 
The prokaryotic 70s ribosome is formed after assembly of the 
two constituting subunits, characterised as SOS and 30s in 
terms of sedimentation coefficients. For a given protein to 
be synthesised, genetic instructions are carried to the ribosome 
by means of messenger RNA (mRNA). Initially, the mRNA 
associates with the 30s subunit and an initiator transfer RNA 
(tRNA) molecule which binds to the appropriate start codon, 
in a catalytic process that is dependent on cytosolic protein 
factors. The SOS subunit joins the ensemble to form a func- 
tional particle, leaving the 70s ribosome in the state of an 
initiation complex. This step is the first of the three phases 
in protein synthesis: initiation, elongation, and termination. 
When a stop codon is exposed on the operating ribosome, 
release factors enter the scene and termination is effected. 
Catalytically, the ribosome itself is central to the process of 
peptide chain elongation, but three additional protein factors 
are crucial to promote the reaction: elongation factor Tu (EF- 
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Tu), nucleotide exchange factor Ts (EF-Ts), and elongation 
factor G (EF-G) [2-51. A ternary complex of EF-Tu, amino- 
acyl-tRNA (aa-tRNA) and guanosine triphosphate (GTP) fa- 
cilitate the recognition of an exposed codon on the mRNA, 
placing the aa-tRNA at the ribosomal A-site. The binary 
complex of guanosine diphosphate (GDP) and EF-Tu pro- 
duced by ribosome induced hydrolysis, is then expelled from 
the A-site. Exchange of GDP for GTP to regenerate active 
EF-Tu:GTP, which can interact with another aa-tRNA, is 
mediated by EF-Ts. Peptide transfer from a peptidyl-tRNA 
in the ribosomal P-site to the aa-tRNA at the A-site is cata- 
lysed by a peptidyltransferase center on the ribosome. Trans- 
location of deacylated P-site tRNA to the exit site (E-site) and 
A-site peptidyl-tRNA to the P-site, is catalysed by EF-G and 
cause the next codon on the mRNA to be exposed at the A- 
site for yet another round of processive protein synthesis [6]. 
Prokaryotic protein biosynthesis is the target for a wide 
range of antibiotics, and many are natural products [4,7]. 
Kirromycin is one in a family of antibiotics acting specifically 
on elongation factor Tu, binding in a stoichiometric one-to- 
one ratio. Nearly, all of the characteristics displayed by EF- 
Tu in peptide chain elongation are affected by the presence of 
kirromycin [8]. Briefly, formation of a EF-Tu:EF-Ts complex 
from EF-Tu:GDP and EF-Ts is prevented, EF-Tu:GDP/GTP 
equilibria are altered, EF-Tu mediated transfer of aa-tRNA to 
the A-site can take place in the absence of GTP, and the 
dependence on ribosomes and aa-tRNA for expression of 
EF-Tu GTPase activity is released [9]. 
Biochemical and biophysical studies have indicated some 
degree of structural alteration caused by the presence of kir- 
romycin in general, EF-Tu:GDP showing the most profound 
change adapting what has been described as an EF-Tu:GTP- 
like conformation [9%12]. EF-Tu, GTP, and aa-tRNA can still 
interact sequentially in the presence of kirromycin, thus form- 
ing a quaternary complex EF-Tu : GTP : aa-tRNA : kirromycin 
(QC). Although GTP hydrolysis occur readily at the riboso- 
ma1 A-site, EF-Tu:GDP is no longer ejected from the ribo- 
some, thus subsequent peptide-bond formation and further 
progress of protein biosynthesis is obstructed [8]. 
Macromolecules acting at the elongation step of translation 
have been the target for crystallographic investigations for 
decades. In 1968, the first report on diffracting crystals of E. 
coli initiator tRNA appeared [13], and EF-Tu:GDP was first 
crystallized in 1973 [14]. The structure of yeast tRNAPh” was 
solved in 1974 [ 15,161, and crystallographic studies over nearly 
two decades have resulted in refined structures of EF- 
Tu :GDP from two species ([ 171, [ 181 and references therein). 
The structures of EF-Tu from T. thermophilus [19] and T. 
aquaticus [20] in their GTP conformation have been deter- 
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method using a BSA standard and by liquid scintillation counting of 
[‘4C]Phe-tRNAPh”. The presence of EF-Tu and Phe-tRNAPhe in the 
fractions, as well as in the crystals, was verified by silver-stained SDS- 
PAGE. 
mined as complexes with a GTP analog, EF-Tu:GDPNP, and 
recently the EF-Tu:EF-Ts complex from E. coli added to the 
list of solved structures [21]. Crystal structures have also been 
solved of nucleotide-free EF-G [22] and EF-G:GDP [23] from 
i? thermophilus. For years, an essential molecular component 
of protein biosynthesis was inaccessible to X-ray crystallo- 
graphic analysis, despite numerous crystallization attempts 
[24,25], namely the ternary complex of yeast Phe-tRNAPhe : T. 
aquaticus EF-Tu:GDPNP. The crystal structure of this com- 
plex was determined in 1995 [I], after successful crystallization 
[25]. Thus, the overall spatial structures of the macromolecu- 
lar components of the quaternary complex Phe-tRNAPhe:EF- 
Tu:GDPNP:kirromycin, reported on in this article, are 
known, thereby enabling a molecular replacement approach 
to be applied for structure determination. 
Several kirromycin-resistant EF-Tu mutants have been iso- 
lated and found to involve a limited number of residues, lo- 
cated at the interface between domains I and III in the EF- 
Tu:GTP crystal structure [26]. Chemical cross-linking data 
implied that kirromycin is proximate to the conserved wild- 
type residue Lys357, in the presence of aa-tRNA [27]. Trun- 
cated EF-Tu from E. coli, i.e., domains II and III only, does 
not bind the antibiotic [28]. The effect of kirromycin on EF- 
Tu has been most extensively studied in E. coli, but EF-Tu 
from T. thermophilus, as used in this study, is equally sensitive 
[26,29]. 
Elongation factor Tu is a monomeric protein of 393 amino 
acid residues in E. coli, while the T. thermophilus variant is 
only slightly larger and has 405 residues. Both yeast and E. 
coli tRNAPhe has 76 nucleotides, and kirromycin has a mo- 
lecular weight of 797 Da. Here we report the isolation and 
crystallization of quaternary complexes of Phe-tRNAPhe from 
yeast and E. coli with EF-Tu:GDPNP:kirromycin from 
T. thermophilus and E. coli. The eventual structure determina- 
tion by X-ray crystallography of the quaternary complex will 
provide a new basis to evaluate the action of kirromycin-like 
antibiotics in protein biosynthesis, and will undoubtedly be of 
value in the design of drugs against infectious diseases. 
2. Materials and methods 
EF-Tu:GDP was purified from Escherichiu co/i (MRE600) and 
Thermus thermophilus (DSM, No. 576, Germany). A full conversion 
of EF-Tu:GDP to EF-Tu:GDPNP was achieved by adding three 
units of a soluble alkaline phosphatase (Bohringer, Germany) per 
mg EF-Tu and a 5-fold excess of GDPNP to the protein solution 
[20,25], followed by incubation for 30 min at room temperature in 
the presence of a 5 times molar excess of kirromycin (Sigma). The 
mixture was subjected to ion exchange chromatography on a DEAE- 
Sepharose column as described in [30], allowing the alkaline phospha- 
tase to be separated from EF-Tu:GDPNP:kirromycin before the ul- 
timate complex formation with Phe-tRNAPhe. The fractions contain- 
ing EF-Tu bound kirromycin were concentrated in Centricon- 
tubes. Charging of tRNA Phe from brewers yeast (Bohringer, Ger- 
manv) and E. coli (Sigma) was mediated bv incubation with V4C1Phe, 
ATP and cognate Ph;-tRNA synthethase -[31]. The quaternary corn- 
plex (QC) formed by combining equimolar amounts of Phe-tRNAPhe 
and EF-Tu:GDPNP:kirromycin was added a further 2 times molar 
excess of the antibiotic and 30% ammonium sulphate (AS). Centrifu- 
gation of the sample before chromatography produced a slightly yel- 
low pellet, indicating that the excess of kirromycin did not dissolve 
easily. The final chromatography of QC was carried out at pH 7.0 on 
a TSK Phenyl-SPW HPLC column (50 mM Tris-HCI, 10 mM MgCls, 
0.5 mM DTT and AS gradient from 30 to 0.3%). The 0.5 ml QC 
fractions were collected in Eppendorf tubes and precipitated by direct 
addition of AS to 70%. Concentrations were estimated by a Bradford 
3. Results and discussion 
Many biochemical studies on interactions between EF-Tu 
and kirromycin have addressed the issue of affinity, i.e., pro- 
viding binding and rate constants. The EF-Tu:GTP:kirromy- 
tin and EF-Tu:GDP:kirromycin complexes have been re- 
ported to be the more stable, with close to equal binding 
constants in the nanomolar range, while quaternary com- 
plexes of aa-tRNA and EF-Tu:GDP or EF-Tu:GTP with 
the antibiotic are of a more labile nature with reported equi- 
librium constants on a micromolar scale [32]. However, with 
the aim of crystallizing a macromolecular entity, it should be 
noted that the real questions are whether isolation is feasible 
and whether stability under conditions that can support crys- 
tal growth is obtainable. 
Attempts in different laboratories have been made to get 
structural information on the kirromycin interactions, by 
soaking preformed crystals of both EF-Tu:GDP and EF- 
Tu:GDPNP in antibiotic containing solutions [9]. It seems 
that crystal packing have rendered these trials unsuccessful. 
In the present study, co-crystallization experiments were per- 
formed with E. coli EF-Tu:GDPNP, but all attempts resulted 
in fibrillar formations as in [33]. We tried to isolate complexes 
of EF-Tu : GDP : kirromycin with deacylated and phenylalanyl- 
ated yeast tRNA, but were unable to observe the formation of 
such complexes under our experimental conditions. 
Ammonium sulphate (AS) is known to increase the stability 
of ternary complexes [25,31,34,35], as well as being a useful 
precipitant for the crystallization of binary complexes of EF- 
Tu, thus making it reasonable to consider this salt for the 
purification and crystallization of the Phe-tRNAPhe :EF- 
Tu:GDPNP:kirromycin complex (QC). The complex was sep- 
arated by hydrophobic interaction chromatography on a 
phenyl substituted HPLC column (see Section 2 and Fig. 1). 
This procedure obviated the need for further purification by 
Fig. 1. The components of the quaternary complex were incubated 
and separated by hydrophobic interaction chromatography. a: Free 
nucleotides, tRNAPh”, Phe-tRNAPhe and kirromycin. b: Phe- 
tRNAPh”:EF-Tu:GDPNP:kirromycin. c: EF-Tu:GDPNP:kirromy- 
tin. 
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Fig. 2. Single crystals of quaternary complexes. A: Rhombohedral crystal of yeast Phe-tRNAPhe: T. thermophilus EF-Tu:GDPNP:kirromycin. 
B: Cubic crystals of yeast Phe-tRNAPhe: E. coli EF-Tu:GDPNP:kirromycin. 
reverse fractional extraction [25]. The intensity of the charac- 
teristic kirromycin absorption at 335 nm is known to decrease 
upon binding to EF-Tu, while the maximum position is un- 
affected [8]. In an equivalent purification of the ternary com- 
plex, no detectable absorption in the neighbourhood of this 
red-shifted wavelength was observed. The crystallization pro- 
cedure was the same for the different variant complexes in this 
study. Precipitated fractions from the central part of the QC- 
peak were combined and added a 2-fold molar excess of kir- 
romycin. The precipitate was collected by centrifugation and 
redissolved in crystallization buffer at a concentration of 34 
mg QClml (50 mM Tris-HCl, 10 mM MgC12, 0.5 mM DTT, 
0.5 mM GDPNP, 30% AS). Equilibration at 4°C of 10 pl 
droplets on siliconized cover slips placed over the reservoirs 
(4549% AS, 10 mM Mes, 3.9 mM Tris-HCl, pH 6.4) resulted 
in crystal growth within 3-l days. 
Fig. 3. Silver-stained gradient gel of washed and redissolved crystals 
(SDS-PAGE, 12.5-250/o). Lanes a,e: E. cob EF-Tu molecular weight 
marker (43 kDa). Lane b: Outdated crystals of the ternary complex 
[25] used as a standard to indicate a 1 :l molar ratio of EF-Tu/ 
tRNAPhe. Lane c: Crystals of yeast Phe-tRNAPhe:T. thermophilus 
EF-Tu:GDPNP:kirromycin. Lane d: Crystals of yeast Phe- 
tRNAPhe:E. coli EF-Tu:GDPNP:kirromycin. 
For the yeast Phe-tRNAPhe : E. coli EF-Tu : GDPNP : kirro- 
mycin complex single crystals of maximum size 0.2 X 0.2 X 0.2 
mm3 and for E. coli Phe-tRNAPhe : E. coli EF-Tu:GDPNP:- 
kirromycin sizes of 0.03 X 0.03 X0.03 mm’, were obtained 
within 2 weeks. Morphologically, these crystal are indistin- 
guishable and so it is believed that the source of the tRNA 
has no significant structural implication. A similar time span 
was needed for rhombohedral crystals of yeast Phe- 
tRNAPhe: T. thermophilus EF-Tu:GDPNP:kirromycin to 
grow to a size of 0.5 X0.5X0.5 mm3 (Fig. 2). The presence 
of EF-Tu and Phe-tRNAPhe in the crystals was verified by 
silver-stained SDS-PAGE of redissolved crystals after careful 
washing (Fig. 3). 
Collection of diffraction data from the reported crystals is 
feasible only by the use of intense synchrotron radiation. A 
low-resolution data set to 3.5 A was measured at SRS, Dares- 
bury (station 9.6) on the yeast Phe-tRNAPhe:E. coli EF- 
Tu : GDPNP : kirromycin complex using a sucrose concentra- 
tion of 25% at cryogenic temperatures. The crystals belong t,o 
the cubic spacegroup P432, with cell dimensions of 196.26 A. 
The diffraction limit extends beyond 3 A with sufficient ex- 
posure provided. Judged from spot shape, background ap- 
pearance and a mosaicity of 0.2” for the collected data, the 
crystals seem well ordered. It should be noted that unstable 
hexagonal plates were obtained in attempts to produce crys- 
tals of the ternary complex from E. coli EF-Tu:GDPNP and 
yeast Phe-tRNAPhe [25]. Assuming a realistic solvent content, 
calculations give one quaternary complex per asymmetric 
unit. 
The crystals of yeast Phe-tRNAPhe:T. thermophilus EF- 
Tu : GDPNP : kirromycin were likewise tested at Daresbury. 
The diffraction potential was similar to that of the E. coli 
complex, possibly with slightly less demand to radiation in- 
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tensity. The crystal system is rhombohedral with cell dimen- 
sions of 137.3 A and angles of 54.0”. The asymmetric unit is 
estimated to contain one quaternary complex. 
[I31 
The crystallization of the quaternary complex reported here 
provides the basis for an eventual structure determination by 
X-ray crystallography, that will be a valuable supplement to 
our understanding of kirromycin action. Elongation factor G 
is affected by the antibiotic fusidic acid and also by kirromy- 
tin but at very high concentrations [8,36]. Considering the 
revealed similarity between the ternary complex and EF-G 
[l], the results from a crystallographic analysis made possible 
through this study may be of more general interest. Further- 
more, the structure of the quaternary complex is expected to 
reveal new details concerning the GTPase activity, and thus 
will provide further support for speculations on this issue. 
[I41 
I151 
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